Product Description
| Cat Number | PP-380 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Binds to PD-L1 |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions |
| Sequence Three Letter Code | H-Cys-Val-Arg-Ala-Arg-Thr-Arg-OH |
| Molecular Formula | C33H64N16O9S |
| Sl Sequence | CVRARTR |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Gurung et al (2020) Phage display-identified PD-L1-binding peptides reinvigorate T-cell activity and inhibit tumor progression. 247 119984 PMID: 32278214Park et al (2022) Abstract 3422: Combined treatment with interleukin-4 receptor-targeted cytotoxic peptide and PD-L1-blocking peptide efficiently induces immunogenic cell death of tumor cells and activates T-cell activity. Cancer Res 82 (12 Supplement) 3422. https://doi.org/10.1158/1538-7445.AM2022-3422 Related areasAll peptides >All protein-protein interaction modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: